BLOG

36 Hours in New Orleans – Part 2

October 17, 2019 by CHEST Market Growth Team

Looking for a different view of the city? If you get up early enough (this may be difficult for those who stayed up late at the Sazerac Bar), this is your chance. This is a time when the French Quarter gets to work on resupplying the stock of food and drink consumed [Read more...]

Category: CHEST 2019

Related Topics: New Orleans


Games at CHEST Annual Meeting

October 15, 2019 by Chad Jackson, MS, RRT, FCCP

Let’s change the rules on how people learn. If I had to define the mission statement of CHEST Games, it would be something like that or more simply—let’s make this fun.   We have the perfect location for fun this year: New Orleans. It’s a town that even provides a term for what CHEST Games [Read more...]

Category: CHEST 2019

Related Topics: Games


Industry News: FDA Approves New Treatment for Excessive Daytime Sleepiness

August 29, 2019 by CHEST Market Growth Team

Sleep doctors have a potential new tool to assist patients with narcolepsy. The US Food and Drug Administration approved Waxix® (pitolisant), a once-daily, selective histamine 3 (H3) receptor antagonist. The approval marks the first time that a treatment for narcolepsy is not scheduled as a controlled substance by [Read more...]

Category: Industry News

Related Topics: CHEST Data Lab, Narcolepsy, Sleep, Sleep Clinicians, Waxix


36 Hours in New Orleans – Part 1

August 28, 2019 by CHEST Market Growth Team

Thinking about attending the CHEST Annual Meeting in New Orleans this year? Here are some reasons to make a trip of it, and enjoy some local flavor prior to joining thousands of clinicians at the premier educational event.

Category: CHEST 2019

Related Topics: CHEST Meeting 2019, New Orleans


Industry News: Precision Medicine in Study and Practice for Detecting Lung Cancer

August 8, 2019 by CHEST Market Growth Team

When will clinicians feel comfortable using emerging technologies including genomic tests to detect lung cancer? The topic is addressed in the recently released CHEST Clinical PerspectivesTM white paper “Precision Medicine: Adoption of Emerging Methods of Evaluation and Therapy,” which examines personalized medicine adoption, including the testing of biomarkers [Read more...]

Category: Clinical Perspectives

Related Topics: biomarkers, Lung Cancer, Precision Medicine


CHEST Clinical Perspectives™ Explores the Emerging Field of Precision Medicine

July 17, 2019 by CHEST Market Growth Team

For clinicians seeking to provide a unique way to treat or diagnose a patient, a recent study found that the issues go beyond awareness or patients feeling comfortable—there remains the question of something as simple as: what should we call it?  Clinicians remain uncertain whether to name the [Read more...]

Category: Clinical Perspectives

Related Topics: biomarkers, Personalized Medicine, Precision Medicine


1 2